Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis
Conditions: Liver Cancer; Liver Cirrhoses; Liver Carcinoma Intervention: Drug: Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid Sponsors: University of California, San Diego; Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma; Icahn School of Medicine at Mount Sinai Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Cirrhosis | Hepatocellular Carcinoma | Liver Cancer | Nutrition | Pharmaceuticals | Research | Ultrasound